Supporting the advancement of Chronic Lung Disease treatment
OVERVIEW:
From our experience over the past six months it seems that everyone has some connection or affiliation with a premature infant. We hope more than anything, that your own child, niece, nephew, sibling, friend’s child, or other personal connection who was a preemie had a more fortuitous outcome than Remy and is currently thriving. Tragically, hundreds of thousands of preemies are afflicted with chronic lung disease every year and many of them do not survive or carry on with minimal quality of life. 10-12% of all babies are born prematurely (15,000,000 globally and 400,000+ in the US annually) and the biggest ongoing issue among preemies is lung disease (as the lungs are the last major organ to develop before birth).
Please help us create a better future with the Remy Foundation. With your help, contributing to the Remy Foundation and spreading awareness of chronic lung disease we can one day give all (premature) infants a fair shot at life
The Remy Foundation raises money and awareness for pediatric chronic lung disease. 100% of what we raise will support the development of a breakthrough advancement in development at the Children’s Hospital of Philadelphia. This initiative is developing a liquid ventilation technology for babies with lung issues that require respiratory support. Currently, many premature infants are put on traditional air (gas) ventilation support, which saves hundreds of thousands of lives per year. However, the oxygen support in its current medium (gas form) can be very damaging to the lungs, brain, eyes, and other organ systems. The risks and long-term damage are well known but it is currently the best option. Medical professionals do their best to mitigate the damage; minimizing the oxygen support level as much as possible, duration of time an infant is on support, and careful selection of various equipment options. The liquid ventilation technology will be a drastically smoother and gentler delivery mechanism for oxygen support. In situations where the infant is unable to ween off (current) ventilator support, or they are a mysterious or complicated case (like Remy), time is of the utmost criticality. The thing most responsible for keeping an infant with chronic lung disease alive is also deteriorating vital organs and decreasing their chances of long-term quality of life. With liquid ventilation, an infant with chronic lung disease or bronchopulmonary dysplasia will have the luxury of more time, which will enable the brilliant neo-natologists and NICU nurses (the unsung heroes) a better chance of helping the baby survive and thrive without the associated long-term damage from the traditional air ventilator.
From our experience over the past six months it seems that everyone has some connection or affiliation with a premature infant. We hope more than anything, that your own child, niece, nephew, sibling, friend’s child, or other personal connection who was a preemie had a more fortuitous outcome than Remy and is currently thriving. Tragically, hundreds of thousands of preemies are afflicted with chronic lung disease every year and many of them do not survive or carry on with minimal quality of life. 10-12% of all babies are born prematurely (15,000,000 globally and 400,000+ in the US annually) and the biggest ongoing issue among preemies is lung disease (as the lungs are the last major organ to develop before birth).
Please help us create a better future with the Remy Foundation. With your help, contributing to the Remy Foundation and spreading awareness of chronic lung disease we can one day give all (premature) infants a fair shot at life
The Remy Foundation raises money and awareness for pediatric chronic lung disease. 100% of what we raise will support the development of a breakthrough advancement in development at the Children’s Hospital of Philadelphia. This initiative is developing a liquid ventilation technology for babies with lung issues that require respiratory support. Currently, many premature infants are put on traditional air (gas) ventilation support, which saves hundreds of thousands of lives per year. However, the oxygen support in its current medium (gas form) can be very damaging to the lungs, brain, eyes, and other organ systems. The risks and long-term damage are well known but it is currently the best option. Medical professionals do their best to mitigate the damage; minimizing the oxygen support level as much as possible, duration of time an infant is on support, and careful selection of various equipment options. The liquid ventilation technology will be a drastically smoother and gentler delivery mechanism for oxygen support. In situations where the infant is unable to ween off (current) ventilator support, or they are a mysterious or complicated case (like Remy), time is of the utmost criticality. The thing most responsible for keeping an infant with chronic lung disease alive is also deteriorating vital organs and decreasing their chances of long-term quality of life. With liquid ventilation, an infant with chronic lung disease or bronchopulmonary dysplasia will have the luxury of more time, which will enable the brilliant neo-natologists and NICU nurses (the unsung heroes) a better chance of helping the baby survive and thrive without the associated long-term damage from the traditional air ventilator.